Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure.
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
There is no randomised controlled trials to determine the clinical effects of long term Non-Invasive Ventilation in Cystic Fibrosis patients.
| Condition | Intervention | Phase |
|---|---|---|
|
Cystic Fibrosis Chronic Respiratory Failure |
Device: pressure support ventilator |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Evaluation of the Effects of Long Term Non-Invasive Ventilation in Patient With Cystic Fibrosis and Chronic Hypercapnic Respiratory Failure. |
- The effect of non-invasive ventilation on room air PaCO2 at one year: Hypothesis is PaCO2 stabilisation in the non-invasive ventilation group compared to a increase in PaCO2 in the control group (standard treatment) [ Time Frame: ended 2011 ] [ Designated as safety issue: No ]
- Effects of non-invasive ventilation on dyspnea index, functional status (6 minutes walking test, spirometric values), pulmonary exacerbations and body mass index (BMI) compared to standard treatment. [ Time Frame: ended 2011 ] [ Designated as safety issue: No ]
| Enrollment: | 36 |
| Study Start Date: | May 2005 |
| Study Completion Date: | May 2011 |
| Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: Usual medical therapy
Usual CF care
|
|
|
Experimental: Non-invasive ventilation
Pressure support ventilator (SAIME,AIROX)
|
Device: pressure support ventilator
Non invasive ventilation 4h/d 5 days a week
|
Detailed Description:
The effects of long term mechanical ventilation for the treatment of respiratory failure in patients with neuromuscular diseases is well established.
Long term non-invasive ventilation is commonly used in the treatment of Cystic Fibrosis patients with respiratory failure. However, the benefits of this treatment have never been studied in randomized control trials and are unknown.
The goal of this multicenter study is to evaluate the effects of the addition of non-invasive ventilation to the standard therapy in stable Cystic Fibrosis patients with chronic hypercapnia.
Two groups of patients will be followed: The first group will receive standard treatment for advanced Cystic Fibrosis according to international guidelines, the second group will receive the same treatment plus non-invasive ventilation (4H/day). The follow up time will be one year for each patient.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Confirmed diagnosis of Cystic fibrosis
- Chronic hypercapnia on room air in stable condition (PaCO2 between 45 and 55mmHg in two occasions separated by more than 4 weeks)
- Informed consent
Exclusion Criteria:
- Current treatment with non-invasive ventilation
- PaCO2 more than 55 mmHg
- Recent pneumothorax (within past 3 months)
Contacts and Locations| France | |
| Department of pulmonary disease of Cochin Hospital (AP-HP) | |
| Paris, France, 75679 | |
| Principal Investigator: | Pierre-Régis Burgel | Department of pulmonary disease of Cochin Hospital (AP-HP) |
More Information
Publications:
| Responsible Party: | Dr Pierre-Régis Burgel, Professor, Cochin Hospital |
| ClinicalTrials.gov Identifier: | NCT00208078 History of Changes |
| Other Study ID Numbers: | 2206/08-11-04 |
| Study First Received: | September 13, 2005 |
| Last Updated: | February 12, 2013 |
| Health Authority: | France: Ministry of Health |
Keywords provided by Cochin Hospital:
|
Hypercapnia Non-Invasive Ventilation |
Additional relevant MeSH terms:
|
Cystic Fibrosis Fibrosis Hypoventilation Respiratory Insufficiency Pancreatic Diseases Digestive System Diseases Lung Diseases |
Respiratory Tract Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Pathologic Processes Respiration Disorders Signs and Symptoms, Respiratory Signs and Symptoms |
ClinicalTrials.gov processed this record on May 22, 2013